Pay in 4 interest-free payments of $6.90 Learn more
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11
Its primary functions include neutralising free radicals, supporting immune health, and detoxifying harmful substances, including alcohol byproducts
That requires doing research and clinical trials to prove efficacy
Xtandi (enzalutamide) Disease area(s): Oncology Manufacturer(s): Astellas/Pfizer 2024 Sales (USD): $7.94 billion Why it sold so well: In 2024, Astellas Pharmas Xtandi, co-marketed with Pfizer, posted strong sales growth, with revenues reaching 703.1 billion ($4.64 billion) for the first nine months (April 1, 2024 to December 31, 2024), marking a 25.6% increase compared to the same period in the previous year
Call, do not email
Current NICE guidance for alcohol use disorder (CG115) recommends a stepped-care approach beginning with brief interventions and psychological therapies, progressing to specialist assessment and treatment for moderate to severe AUD
US$ 23.71
US$ 27.80
US$ 20.30
US$ 20.25
